Europe

This archive covers progress stories and milestones from across Europe, spanning health, climate policy, social equity, and scientific research. From small-nation experiments to E.U.-wide initiatives, these reports highlight what is working and why.

Bee on yellow flowers, for article on EU nature restoration law

E.U. passes landmark law to restore 20% of Europe’s degraded land and sea by 2030

By / / Good News For Humankind

The EU nature restoration law is now official, requiring all 27 member states to put restoration measures in place across at least 20% of Europe’s land and seas by 2030, with every degraded ecosystem on track for repair by 2050. It’s the first legally binding restoration target in EU history, with enforceable milestones, national plans, and consequences for falling behind. Among its boldest commitments: rewetting drained peatlands, freeing 25,000 kilometers of rivers from obsolete dams and barriers, and reversing pollinator decline by the end of the decade. Coming after a razor-thin parliamentary vote and months of political resistance, the law shows that a major democracy can still choose to act on ecological collapse — offering a template the rest of the world can learn from.

3d illustration of gut and stomach pain, for article on Crohn's disease remission

79% of Crohn’s disease patients in remission after early intervention

By / / Good News For Humankind

Crohn’s disease patients given the drug infliximab right after diagnosis reached sustained remission at a rate of 79% after one year, compared to just 15% for those on the standard step-by-step approach. The Cambridge-led trial of 386 patients also found that only one person in the early-treatment group needed urgent bowel surgery, versus ten in the conventional group. Researchers say the old wisdom of saving the strongest drugs for last lets quiet damage build up while the clock ticks. With cheaper biosimilar versions now widely available, this finding could reshape care for the millions living with Crohn’s worldwide — and it’s a powerful reminder that sometimes the best medicine is simply not waiting.

A researcher examining lung cancer scans in a clinical setting for an article about mesothelioma survival rates, for article on mesothelioma survival rates

New drug quadruples three-year survival rates for mesothelioma in international trial

By / / Good News For Humankind

Mesothelioma survival rates have quadrupled over three years thanks to a drug that starves tumors of a key nutrient, marking the first successful new treatment combination for the disease in 20 years. The international ATOMIC-meso trial, led by Queen Mary University of London and published in JAMA Oncology, found that patients receiving pegargiminase alongside standard chemotherapy were significantly more likely to be alive three years later. The drug works by depleting arginine in the bloodstream, cutting off a nutrient that mesothelioma cells cannot produce themselves. For a cancer caused by asbestos exposure that has historically offered patients months rather than years, this breakthrough represents a genuine turning point.

Good news for LGBTQ rights, for article on Thailand marriage equality, for article on conversion therapy ban, for article on same-sex partnership rights, for article on forced outing of queer students, for article on Greece same-sex marriage

Greece legalizes same-sex marriage

By / / Good News For Humankind

Same-sex marriage is now legal in Greece after parliament voted 176 to 76, making it the first Orthodox-majority country in the world to embrace marriage equality. The new law also gives same-sex couples the right to adopt, ending years of legal limbo for families who had been raising children without basic protections like inheritance, hospital visitation, or shared parental authority. Prime Minister Kyriakos Mitsotakis, whose own party was split, framed the vote around children who had long been invisible to the law finally finding their place. Passed despite strong opposition from the Greek Orthodox Church, the decision is a quiet but powerful signal that deep religious tradition and full legal equality can coexist.

Woman wearing head covering, for article on gender-based violence

E.U. reaches first-ever agreement to eliminate various forms of violence against women

By / / Good News For Humankind

The European Union just agreed to its first-ever continent-wide law protecting women from gender-based violence, covering all 27 member states. The deal requires every country to set up helplines, rape crisis centers, and survivor support services, and it criminalizes cyberstalking and online harassment with shared definitions across borders. It directly names harms like female genital mutilation and forced marriage, creating enforceable protections where none existed before. Lawmakers acknowledge real gaps — including the absence of a consent-based definition of rape — but built in a review every five years to keep strengthening the rules. For a crisis that touches one in three women in Europe, it’s a foundation the next generation of advocates can build on.

Aerial view of container ship

Decarbonization containers turn 78% of marine emissions into limestone in new pilot

By / / Good news links

A remarkable pilot project installed on a 787-ft. container ship has proven it’s possible to capture emissions from the smokestacks of cargo ships with 78% efficiency and convert the CO2 into limestone pebbles, which can be offloaded and sold. London startup Seabound, funded by a US$1.5-million grant from the UK Government, partnered up with global shipping company Lomar to install the carbon capture equipment on one of its older and dirtier-burning ships, a medium-sized vessel capable of carrying more than 3,200 shipping containers.

Assortment of pills, for article on AI antidepressant prediction

Novel AI model rapidly determines if an antidepressant will work

By / / Good News For Humankind

Antidepressant treatment has long meant weeks of waiting, side effects, and uncertainty — and for around 60% of people with depression, the first medication simply doesn’t work. Dutch researchers developed an AI model that predicts within one week whether sertraline will help a patient by reading brain blood flow patterns and early symptom changes, potentially allowing clinicians to pivot sooner for those unlikely to respond. The model is limited to sertraline and requires further validation before clinical use — but it points toward a future where prescribing depression treatment looks less like guesswork and more like precision medicine.

Wind turbines amid clouds, for article on E.U. wind power, for article on renewable electricity generation

Wind power overtakes natural gas in the E.U. for first time ever

By / / Good News For Humankind

Wind energy outproduced natural gas across the European Union for the first time ever in 2023, according to an analysis from the energy think tank Ember. Renewables together supplied nearly half of Europe’s electricity that year, while coal generation fell by 26 percent — the steepest single-year drop the continent’s power sector has ever recorded. Analyst Sarah Brown called it a “monumental shift,” noting that wind and solar are now becoming the backbone of the grid rather than an add-on. What makes this especially hopeful is that it happened during an energy crisis, when many expected Europe to retreat to coal. Instead, the continent leaned harder into clean power — and showed the rest of the world what’s possible.

Woman putting organic waste in the compost bin

France implements compulsory composting

By / / Good news links

As of January 2024, municipalities in France must now provide residents with ways to sort bio-waste, which includes food scraps, vegetable peels, expired food and garden waste. Households and businesses are required to dispose of organic matter either in a dedicated small bin for home collection or at a municipal collection point. The waste will then be turned into biogas or compost to replace chemical fertilizers.

Empty office desk and chairs, for article on four-day workweek trial

Germany launches large four-day workweek trial

By / / Good News For Humankind

Four-day workweek research is gaining serious momentum, and Germany’s new pilot puts it to the test in one of the world’s most productivity-focused economies. Forty-five companies joined a six-month trial, maintaining full pay while cutting hours by 20% — a genuine business bet, not an academic exercise. Earlier U.K. trials showed promising results, though critics note that only companies already suited to compressed schedules tend to volunteer, limiting how broadly findings apply. Still, each new dataset strengthens the global case that working less might mean working better.